Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Robert Page

Concepts (754)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
39
2026
2323
4.280
Why?
Substance Abuse Detection
5
2026
110
2.170
Why?
Acute Coronary Syndrome
8
2022
299
1.620
Why?
American Heart Association
13
2026
363
1.610
Why?
Immunosuppressive Agents
11
2024
824
1.590
Why?
Substance Abuse, Intravenous
2
2026
131
1.580
Why?
Cardiovascular Agents
7
2018
165
1.440
Why?
Heart Transplantation
16
2026
679
1.360
Why?
Medical Marijuana
4
2024
119
1.310
Why?
Atrial Fibrillation
17
2026
559
1.310
Why?
Health Resources
4
2016
130
1.300
Why?
Needle-Exchange Programs
2
2026
16
1.170
Why?
Stroke Volume
9
2026
651
1.100
Why?
Substance-Related Disorders
5
2025
1098
1.100
Why?
Graft Rejection
7
2025
504
1.050
Why?
Marijuana Smoking
2
2021
248
1.010
Why?
Anti-Arrhythmia Agents
13
2014
144
1.000
Why?
Humans
187
2026
145625
0.990
Why?
Polypharmacy
5
2023
94
0.980
Why?
Adrenergic beta-Antagonists
9
2019
252
0.980
Why?
Drug Contamination
1
2026
56
0.950
Why?
Drug Interactions
14
2021
403
0.940
Why?
Cocaine
3
2024
162
0.930
Why?
Health Expenditures
3
2025
196
0.900
Why?
Music
2
2024
43
0.880
Why?
Cardiovascular Diseases
11
2026
2218
0.870
Why?
Defibrillators, Implantable
11
2001
393
0.860
Why?
Electric Countershock
9
2001
126
0.860
Why?
Drug Overdose
2
2022
376
0.860
Why?
Drug-Related Side Effects and Adverse Reactions
4
2022
266
0.850
Why?
Propanolamines
3
2019
40
0.840
Why?
Opioid-Related Disorders
4
2026
611
0.810
Why?
Cost of Illness
3
2014
322
0.760
Why?
Consensus
3
2024
465
0.750
Why?
Aminobutyrates
1
2023
31
0.750
Why?
Theophylline
1
2022
41
0.720
Why?
Drugs, Generic
2
2020
28
0.710
Why?
Arrhythmias, Cardiac
9
2001
358
0.690
Why?
Remote Consultation
1
2022
67
0.690
Why?
Hospitalization
14
2026
2468
0.680
Why?
Male
99
2026
73014
0.670
Why?
Nucleic Acids
1
2022
73
0.660
Why?
Organ Transplantation
2
2021
235
0.650
Why?
Middle Aged
69
2026
36359
0.640
Why?
Health Care Costs
2
2014
418
0.640
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2019
448
0.630
Why?
Aged
59
2026
26251
0.630
Why?
Sodium Potassium Chloride Symporter Inhibitors
3
2017
17
0.620
Why?
Drug Hypersensitivity
5
2008
93
0.610
Why?
Australia
6
2026
291
0.590
Why?
Cardiovascular System
1
2020
137
0.570
Why?
Inpatients
2
2016
538
0.570
Why?
Anti-Infective Agents
5
2010
234
0.560
Why?
Female
91
2026
79080
0.560
Why?
United States
29
2026
16041
0.550
Why?
gamma-Aminobutyric Acid
2
2011
195
0.550
Why?
Drug Substitution
4
2026
62
0.550
Why?
Adult
51
2026
40821
0.550
Why?
Marijuana Abuse
1
2021
215
0.540
Why?
Prescription Drugs
2
2016
110
0.530
Why?
Practice Guidelines as Topic
5
2025
1581
0.530
Why?
Heart Rate
16
2021
844
0.510
Why?
Tachycardia, Ventricular
10
2001
179
0.500
Why?
Sick Leave
2
2014
16
0.500
Why?
Practice Patterns, Physicians'
5
2024
1370
0.500
Why?
Lung Transplantation
1
2020
326
0.490
Why?
Purines
2
2022
188
0.490
Why?
Pregnancy Complications, Cardiovascular
4
2001
83
0.490
Why?
New South Wales
3
2026
23
0.480
Why?
Chronic Disease
8
2020
1824
0.470
Why?
Angiotensin II Type 1 Receptor Blockers
1
2016
39
0.460
Why?
Drug Costs
3
2025
115
0.460
Why?
Diabetes Mellitus, Type 2
3
2023
2623
0.460
Why?
Ranolazine
1
2015
23
0.450
Why?
Anticoagulants
8
2021
743
0.450
Why?
Renin-Angiotensin System
1
2016
80
0.450
Why?
Treatment Outcome
18
2025
11744
0.450
Why?
Survival
1
2015
38
0.450
Why?
Angina, Stable
1
2015
18
0.450
Why?
Retrospective Studies
23
2025
17291
0.440
Why?
Angiotensin Receptor Antagonists
1
2016
115
0.440
Why?
Prescription Drug Misuse
1
2015
53
0.440
Why?
Public Health
1
2020
573
0.440
Why?
Pharmacists
5
2025
260
0.440
Why?
Cardiac Pacing, Artificial
9
2001
83
0.430
Why?
Hospital Costs
1
2016
127
0.430
Why?
Employer Health Costs
1
2014
3
0.430
Why?
Calcium Channel Blockers
2
2015
165
0.430
Why?
Physical Therapy Specialty
2
2006
55
0.420
Why?
Drug Monitoring
5
2016
399
0.410
Why?
Cytomegalovirus
2
2025
169
0.410
Why?
Vasodilator Agents
5
2016
326
0.410
Why?
Colorado
10
2025
4588
0.410
Why?
Cardiology
4
2024
363
0.410
Why?
Drug Utilization Review
2
2006
60
0.400
Why?
Mortality
2
2015
375
0.400
Why?
Patient Discharge
6
2021
991
0.400
Why?
Pyrazoles
2
2022
516
0.400
Why?
Electrocardiography
18
2013
666
0.400
Why?
Patient Admission
1
2016
216
0.400
Why?
Methadone
2
2026
130
0.400
Why?
Tacrolimus
4
2016
192
0.400
Why?
Angiotensin-Converting Enzyme Inhibitors
3
2023
228
0.400
Why?
Pain
3
2022
787
0.400
Why?
Aged, 80 and over
18
2026
8351
0.390
Why?
Muscular Diseases
2
2019
110
0.390
Why?
Cytomegalovirus Infections
2
2025
203
0.390
Why?
Daptomycin
1
2013
18
0.380
Why?
Catheter Ablation
6
2000
355
0.370
Why?
Creatine Kinase
1
2013
70
0.370
Why?
Hospital Mortality
2
2016
1037
0.370
Why?
Opiate Substitution Treatment
2
2026
195
0.370
Why?
Risk Factors
16
2026
10840
0.370
Why?
Drug Prescriptions
3
2010
290
0.360
Why?
Pharmaceutical Services
1
2013
76
0.360
Why?
Sulfonamides
5
2013
592
0.360
Why?
Baroreflex
5
2021
55
0.360
Why?
Models, Organizational
1
2013
145
0.360
Why?
Efficiency, Organizational
1
2013
142
0.360
Why?
Hiccup
1
2011
2
0.350
Why?
Platelet Aggregation Inhibitors
4
2018
499
0.350
Why?
Cyclohexanecarboxylic Acids
1
2011
19
0.350
Why?
Dietary Supplements
4
2016
586
0.350
Why?
Ventricular Fibrillation
4
2001
63
0.350
Why?
Buprenorphine
2
2026
197
0.340
Why?
Amines
1
2011
40
0.340
Why?
Pharmacy Service, Hospital
4
2015
90
0.340
Why?
Cities
1
2012
140
0.340
Why?
Medicaid
1
2015
472
0.340
Why?
Tachycardia, Atrioventricular Nodal Reentry
5
2000
28
0.330
Why?
Atrioventricular Node
4
1997
15
0.330
Why?
Medication Errors
3
2013
86
0.330
Why?
Cannabinoids
2
2025
181
0.330
Why?
Health Knowledge, Attitudes, Practice
4
2018
1403
0.330
Why?
Analgesics, Opioid
4
2026
1158
0.320
Why?
Patient Education as Topic
3
2013
769
0.320
Why?
Adenosine
3
2018
255
0.310
Why?
Myocardial Infarction
3
2013
1212
0.310
Why?
Aircraft
3
2001
21
0.310
Why?
Heart Conduction System
9
2001
96
0.310
Why?
Venous Thromboembolism
1
2014
330
0.310
Why?
Transplant Recipients
3
2017
168
0.310
Why?
Central Nervous System Agents
1
2009
7
0.300
Why?
Dose-Response Relationship, Drug
8
2024
2018
0.300
Why?
Electrocardiography, Ambulatory
6
1999
64
0.300
Why?
Desensitization, Immunologic
2
2008
91
0.300
Why?
Tobacco Smoke Pollution
1
2012
227
0.300
Why?
Clinical Protocols
3
2017
279
0.290
Why?
Seizures
2
2012
489
0.280
Why?
Electrodes, Implanted
4
1997
113
0.280
Why?
Central Nervous System Diseases
1
2009
73
0.280
Why?
Ventricular Dysfunction, Left
6
2020
391
0.270
Why?
Restless Legs Syndrome
1
2008
20
0.270
Why?
Citalopram
1
2008
33
0.260
Why?
Cost Sharing
1
2008
23
0.260
Why?
Premature Birth
1
2012
389
0.260
Why?
Helicobacter Infections
1
2007
30
0.260
Why?
RNA, Viral
2
2022
691
0.260
Why?
Ticlopidine
1
2008
52
0.260
Why?
Postoperative Complications
4
2025
2962
0.260
Why?
Helicobacter pylori
1
2007
44
0.260
Why?
Pacemaker, Artificial
3
2001
127
0.250
Why?
Exanthema
1
2008
86
0.250
Why?
Zygomycosis
1
2007
6
0.250
Why?
Health Services Accessibility
1
2016
1101
0.250
Why?
Carbazoles
2
2011
53
0.250
Why?
Managed Care Programs
1
2008
137
0.250
Why?
Prasugrel Hydrochloride
2
2018
22
0.250
Why?
Tachycardia, Supraventricular
6
2001
50
0.250
Why?
Imidazolidines
3
2001
10
0.250
Why?
Cyclosporine
3
2010
256
0.240
Why?
Epistaxis
1
2006
16
0.240
Why?
Analgesics
1
2008
231
0.240
Why?
Adverse Drug Reaction Reporting Systems
1
2006
81
0.240
Why?
Holidays
2
2024
8
0.230
Why?
Time Factors
13
2026
7079
0.230
Why?
Risk Assessment
8
2026
3678
0.230
Why?
Health Behavior
1
2012
801
0.230
Why?
Comorbidity
6
2016
1652
0.230
Why?
Caffeine
1
2026
76
0.230
Why?
Telemedicine
1
2015
956
0.230
Why?
Warfarin
4
2021
179
0.230
Why?
Salvage Therapy
1
2007
163
0.230
Why?
Sympathetic Nervous System
5
2001
177
0.230
Why?
Fructose
1
2006
132
0.230
Why?
Prognosis
8
2025
4331
0.220
Why?
Reagent Strips
1
2025
8
0.220
Why?
Triazoles
1
2007
190
0.220
Why?
Metronidazole
1
2005
20
0.220
Why?
Imidazoles
3
2001
244
0.220
Why?
Medication Adherence
5
2018
535
0.220
Why?
Diabetic Neuropathies
1
2006
100
0.220
Why?
Tobacco, Smokeless
1
2024
13
0.220
Why?
Models, Economic
2
2016
63
0.220
Why?
Heroin Dependence
1
2025
33
0.220
Why?
Ventricular Function, Left
4
2023
541
0.210
Why?
Smoking
1
2012
1478
0.210
Why?
Young Adult
9
2025
14240
0.210
Why?
Coronary Disease
2
1998
380
0.210
Why?
Renal Insufficiency, Chronic
2
2025
639
0.210
Why?
Nitrous Oxide
1
2024
34
0.210
Why?
Mood Disorders
2
2016
129
0.210
Why?
Immunoglobulins, Intravenous
1
2025
134
0.200
Why?
Benzodiazepines
1
2025
156
0.200
Why?
Piperazines
3
2001
367
0.200
Why?
Substance Withdrawal Syndrome
1
2026
184
0.200
Why?
Thrombosis
2
2021
397
0.200
Why?
Salaries and Fringe Benefits
2
2014
57
0.200
Why?
Fentanyl
1
2025
126
0.200
Why?
Analgesics, Non-Narcotic
1
2005
130
0.200
Why?
Metoprolol
3
2001
26
0.200
Why?
Particulate Matter
1
2026
328
0.190
Why?
Vagus Nerve
2
1996
92
0.190
Why?
Research Design
1
2009
1139
0.190
Why?
Nurse Clinicians
1
2024
43
0.190
Why?
Cardiac Catheterization
4
2008
569
0.190
Why?
Endrin
1
2022
13
0.190
Why?
Length of Stay
3
2016
1342
0.190
Why?
Valsartan
1
2023
33
0.190
Why?
Adolescent
11
2024
22451
0.190
Why?
Pressoreceptors
2
2021
19
0.190
Why?
Antiviral Agents
2
2025
774
0.180
Why?
Biphenyl Compounds
1
2023
67
0.180
Why?
Aminophylline
1
2022
12
0.180
Why?
Terminal Care
2
2025
284
0.180
Why?
Thiazolidinediones
1
2003
142
0.180
Why?
Follow-Up Studies
10
2025
5397
0.180
Why?
Sodium
1
2023
196
0.180
Why?
Nitroprusside
3
2016
70
0.180
Why?
Drug Therapy, Combination
6
2016
1034
0.180
Why?
Reverse Transcription
1
2022
20
0.180
Why?
Nicotine
1
2024
334
0.180
Why?
Air Pollutants
1
2026
406
0.180
Why?
Fluorobenzenes
2
2013
17
0.180
Why?
Pharmacogenomic Testing
2
2020
63
0.170
Why?
Heart-Assist Devices
2
2021
570
0.170
Why?
Feasibility Studies
1
2026
1125
0.170
Why?
Troponin I
2
2000
74
0.170
Why?
Education, Pharmacy
3
2016
124
0.170
Why?
Automation
1
2022
104
0.170
Why?
Environmental Exposure
1
2026
578
0.170
Why?
Adrenergic alpha-Antagonists
1
2001
34
0.170
Why?
Virus Inactivation
1
2021
13
0.170
Why?
N-Methyl-3,4-methylenedioxyamphetamine
1
2021
11
0.170
Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2021
2
0.170
Why?
Folic Acid
4
2016
197
0.170
Why?
Patient Transfer
1
2024
223
0.170
Why?
Drug Combinations
1
2023
399
0.170
Why?
Clinical Laboratory Techniques
1
2022
96
0.170
Why?
Hyperthermia, Induced
8
2000
119
0.170
Why?
Prospective Studies
9
2026
8087
0.160
Why?
Equipment Failure
6
2001
111
0.160
Why?
Students, Pharmacy
2
2016
96
0.160
Why?
Azithromycin
1
2001
101
0.160
Why?
Cognition Disorders
2
2016
547
0.160
Why?
Administration, Oral
6
2024
867
0.160
Why?
Randomized Controlled Trials as Topic
5
2021
1754
0.160
Why?
Policy Making
1
2021
83
0.160
Why?
Anti-Bacterial Agents
3
2013
1935
0.150
Why?
Tachycardia, Paroxysmal
3
1995
8
0.150
Why?
Equipment Design
6
2001
519
0.150
Why?
Kidney Failure, Chronic
2
2005
582
0.150
Why?
Reflex, Abnormal
1
1999
8
0.150
Why?
Clinical Decision-Making
2
2021
364
0.150
Why?
Immunoglobulin E
1
2021
315
0.150
Why?
Health Services Needs and Demand
2
2016
283
0.150
Why?
Blood Pressure
6
2021
1761
0.150
Why?
Skilled Nursing Facilities
1
2021
152
0.150
Why?
Drugs, Chinese Herbal
1
1999
24
0.150
Why?
Attitude of Health Personnel
2
2018
1212
0.150
Why?
Heart Arrest
3
2001
410
0.150
Why?
Canada
1
2020
430
0.140
Why?
Coated Materials, Biocompatible
1
1999
64
0.140
Why?
Geriatric Assessment
2
2019
238
0.140
Why?
Alzheimer Disease
2
2016
640
0.140
Why?
Cardiologists
1
2018
45
0.140
Why?
Health Personnel
1
2005
750
0.140
Why?
Heart Injuries
1
1999
41
0.140
Why?
Hot Temperature
1
2021
396
0.140
Why?
Exercise Test
3
2021
634
0.140
Why?
Cross-Sectional Studies
5
2022
5875
0.140
Why?
Benzazepines
1
2018
35
0.140
Why?
Glucose
2
2023
1051
0.140
Why?
Monitoring, Ambulatory
1
1999
88
0.140
Why?
Pyrimidines
2
2013
530
0.130
Why?
Heart Septal Defects, Atrial
1
1998
58
0.130
Why?
Triazines
1
1998
48
0.130
Why?
Stevens-Johnson Syndrome
1
1998
37
0.130
Why?
Purinergic P2Y Receptor Antagonists
1
2018
71
0.130
Why?
Medicare
3
2026
907
0.130
Why?
Health Policy
3
2024
399
0.130
Why?
Diuretics
1
2017
66
0.120
Why?
Dexamethasone
1
1999
368
0.120
Why?
Food, Fortified
1
1997
43
0.120
Why?
Nutritional Physiological Phenomena
1
1997
57
0.120
Why?
Mexiletine
1
2016
6
0.120
Why?
Thiocyanates
1
2016
28
0.120
Why?
Palliative Care
1
2025
1032
0.120
Why?
Thiosulfates
1
2016
19
0.120
Why?
Patient Participation
1
2020
454
0.120
Why?
Mitoxantrone
1
1996
14
0.120
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
2
2006
43
0.120
Why?
Tetralogy of Fallot
1
1997
76
0.120
Why?
Amphetamine
1
2016
37
0.120
Why?
Medication Reconciliation
2
2013
31
0.120
Why?
Ventricular Function
1
1996
53
0.120
Why?
Neural Tube Defects
1
1997
67
0.120
Why?
HIV
1
2017
249
0.120
Why?
Immunotherapy
1
2021
669
0.120
Why?
Regression Analysis
6
2016
994
0.120
Why?
Surveys and Questionnaires
5
2024
6050
0.120
Why?
Mineralocorticoid Receptor Antagonists
1
2016
69
0.120
Why?
Professional Role
3
2025
171
0.120
Why?
Rosuvastatin Calcium
2
2013
21
0.110
Why?
Nonprescription Drugs
1
2016
68
0.110
Why?
Hemodynamics
5
2021
1114
0.110
Why?
Amiodarone
3
2001
31
0.110
Why?
Nitroglycerin
1
2015
14
0.110
Why?
Cytochrome P-450 CYP3A
1
2016
93
0.110
Why?
Societies, Pharmaceutical
2
2013
14
0.110
Why?
Omeprazole
2
2007
9
0.110
Why?
Anticonvulsants
1
1998
251
0.110
Why?
Sex Factors
3
2015
2101
0.110
Why?
Anti-Retroviral Agents
1
2017
250
0.110
Why?
Clinical Competence
4
2012
1261
0.110
Why?
Pre-Excitation Syndromes
1
1995
5
0.110
Why?
Healthcare Disparities
1
2022
728
0.110
Why?
Patient Readmission
3
2021
771
0.110
Why?
Patient Safety
2
2016
351
0.110
Why?
Certification
2
2006
117
0.110
Why?
Age Distribution
1
2015
395
0.110
Why?
Insurance, Disability
1
2014
1
0.110
Why?
Cost-Benefit Analysis
2
2015
632
0.110
Why?
Dyslipidemias
1
2016
184
0.110
Why?
Health Services
1
2015
112
0.110
Why?
Partial Thromboplastin Time
1
2014
53
0.110
Why?
Antidotes
1
2016
145
0.110
Why?
Fever
1
1996
320
0.100
Why?
Risk
2
2017
917
0.100
Why?
Hypoglycemic Agents
2
2005
1411
0.100
Why?
Cardiomyopathy, Dilated
2
2005
357
0.100
Why?
Absenteeism
1
2014
51
0.100
Why?
Proton Pump Inhibitors
2
2007
101
0.100
Why?
Comparative Effectiveness Research
1
2015
170
0.100
Why?
Prevalence
3
2023
2852
0.100
Why?
Efficiency
1
2014
102
0.100
Why?
Lymphoma
1
1996
251
0.100
Why?
Surgical Procedures, Operative
1
2017
271
0.100
Why?
Insurance Claim Review
1
2014
85
0.100
Why?
Soft Tissue Neoplasms
4
2000
133
0.100
Why?
Intensive Care Units
3
2019
923
0.100
Why?
Life Style
2
2018
495
0.100
Why?
Costs and Cost Analysis
1
2014
216
0.100
Why?
Societies, Medical
2
2024
901
0.100
Why?
Mass Casualty Incidents
1
2014
52
0.100
Why?
Patient Care Team
2
2025
700
0.100
Why?
Torsades de Pointes
1
2013
23
0.100
Why?
Disease Management
3
2024
649
0.100
Why?
Homicide
1
2014
65
0.100
Why?
Linear Models
1
2016
847
0.100
Why?
Quality Improvement
3
2020
1325
0.100
Why?
Blood Pressure Determination
1
2014
143
0.100
Why?
Hemorrhage
4
2021
824
0.100
Why?
Procainamide
1
1993
6
0.100
Why?
Calcineurin Inhibitors
2
2010
67
0.090
Why?
Graft Survival
2
2025
508
0.090
Why?
Databases, Factual
2
2018
1481
0.090
Why?
Simvastatin
1
2013
58
0.090
Why?
Medical Staff
1
2012
16
0.090
Why?
Blood Coagulation
1
2014
267
0.090
Why?
Multivariate Analysis
2
2016
1531
0.090
Why?
Long QT Syndrome
1
2013
68
0.090
Why?
Adenosine A2 Receptor Antagonists
1
2012
14
0.090
Why?
Pancreatitis
2
2005
146
0.090
Why?
Models, Educational
1
2012
90
0.090
Why?
Radionuclide Imaging
1
2012
116
0.090
Why?
Phenylephrine
3
1999
74
0.090
Why?
Pregnancy
5
2012
7217
0.090
Why?
Maternal Age
1
2012
129
0.090
Why?
Bisoprolol
1
2011
2
0.090
Why?
Acute Disease
3
2018
1033
0.090
Why?
Foundations
1
2011
27
0.090
Why?
Physicians
1
2020
954
0.080
Why?
Case-Control Studies
2
2015
3633
0.080
Why?
Health Services Misuse
2
2020
33
0.080
Why?
Sinoatrial Node
1
1991
27
0.080
Why?
Infant, Small for Gestational Age
1
2012
118
0.080
Why?
Dog Diseases
4
1999
140
0.080
Why?
Prostatic Hyperplasia
1
2011
40
0.080
Why?
Research Report
1
2011
89
0.080
Why?
Chronic Pain
1
2015
302
0.080
Why?
Chi-Square Distribution
1
2012
511
0.080
Why?
Drug Information Services
2
2013
11
0.080
Why?
Residence Characteristics
2
2012
385
0.080
Why?
Dogs
10
2000
516
0.080
Why?
Contraindications
2
2002
88
0.080
Why?
Wounds, Gunshot
1
2014
257
0.080
Why?
Cohort Studies
3
2016
6045
0.080
Why?
Piperidines
1
1992
223
0.080
Why?
Critical Care
2
2016
700
0.080
Why?
Primary Prevention
2
2010
222
0.080
Why?
Heart Atria
3
2000
139
0.080
Why?
Percutaneous Coronary Intervention
1
2015
549
0.080
Why?
DNA
1
2016
1418
0.070
Why?
Quality Assurance, Health Care
2
2013
339
0.070
Why?
Depressive Disorder
1
2012
359
0.070
Why?
Conflict of Interest
1
2009
52
0.070
Why?
Complementary Therapies
1
2010
93
0.070
Why?
Pregabalin
1
2008
12
0.070
Why?
Monoamine Oxidase Inhibitors
1
2008
20
0.070
Why?
Monoamine Oxidase
1
2008
27
0.070
Why?
Polymorphism, Single Nucleotide
1
2016
2228
0.070
Why?
Antiparkinson Agents
1
2008
41
0.070
Why?
Pharmacogenetics
2
2020
176
0.070
Why?
Emergency Medical Services
1
2015
680
0.070
Why?
C-Reactive Protein
1
2010
427
0.070
Why?
Benchmarking
2
2023
192
0.070
Why?
Insurance, Pharmaceutical Services
1
2008
23
0.070
Why?
Cardiomyopathies
3
2017
339
0.070
Why?
Cardiotonic Agents
2
1999
94
0.070
Why?
Ofloxacin
1
2007
17
0.070
Why?
Enzyme Inhibitors
2
2002
820
0.070
Why?
Biological Products
1
2011
257
0.070
Why?
Age Factors
3
2009
3321
0.070
Why?
Levofloxacin
1
2007
21
0.070
Why?
Vascular Diseases
1
2010
251
0.070
Why?
Delphi Technique
1
2009
347
0.070
Why?
Peer Review, Research
1
2008
36
0.060
Why?
Double-Blind Method
3
2015
2064
0.060
Why?
Injections, Intravenous
2
2001
197
0.060
Why?
Drug-Eluting Stents
1
2008
88
0.060
Why?
Combined Modality Therapy
6
2000
1269
0.060
Why?
Atrial Function
2
1999
10
0.060
Why?
Amoxicillin
1
2007
35
0.060
Why?
Mucor
1
2007
6
0.060
Why?
Hypertension
2
2014
1270
0.060
Why?
Vitamin B 12
3
2016
139
0.060
Why?
Hydrochlorothiazide
1
2006
7
0.060
Why?
Hydantoins
3
2001
6
0.060
Why?
Community Pharmacy Services
1
2007
46
0.060
Why?
Accreditation
1
2007
100
0.060
Why?
Atrial Flutter
3
2000
47
0.060
Why?
Angioedema
1
2006
16
0.060
Why?
Neuralgia
1
2008
140
0.060
Why?
Coffee
1
2026
16
0.060
Why?
Metabolic Clearance Rate
2
2005
115
0.060
Why?
Antidepressive Agents
2
2005
234
0.060
Why?
Pharmaceutical Preparations
1
2008
172
0.060
Why?
Professional Autonomy
1
2006
29
0.060
Why?
Creatinine
2
2005
511
0.060
Why?
Clinical Trials as Topic
4
2010
1062
0.060
Why?
Drug Utilization
1
2006
170
0.060
Why?
Education, Continuing
1
2006
42
0.060
Why?
Hospitals, University
1
2006
176
0.060
Why?
Preceptorship
1
2006
68
0.060
Why?
Medical History Taking
1
2006
116
0.060
Why?
Registries
1
2014
2382
0.060
Why?
alpha-Tocopherol
2
2016
33
0.060
Why?
Reproducibility of Results
3
2021
3396
0.060
Why?
Antihypertensive Agents
2
2006
519
0.060
Why?
Norepinephrine
3
2021
201
0.050
Why?
Ovarian Neoplasms
3
2005
598
0.050
Why?
Biotransformation
1
2005
61
0.050
Why?
Disease-Free Survival
1
2007
777
0.050
Why?
Oxidoreductases
1
2005
91
0.050
Why?
Critical Illness
2
2025
905
0.050
Why?
Alcohol Drinking
1
2012
847
0.050
Why?
Harm Reduction
1
2025
49
0.050
Why?
Curriculum
2
2016
1074
0.050
Why?
Pulmonary Disease, Chronic Obstructive
1
2012
926
0.050
Why?
Disease Progression
2
2026
2857
0.050
Why?
Cytochrome P-450 Enzyme System
1
2005
163
0.050
Why?
Odds Ratio
1
2006
1070
0.050
Why?
Incidence
3
2023
2910
0.050
Why?
Cross-Over Studies
1
2026
612
0.050
Why?
Sarcoma
3
2000
209
0.050
Why?
Biological Transport
1
2005
423
0.050
Why?
Reflex
2
1996
69
0.050
Why?
Educational Status
1
2006
466
0.050
Why?
Transplantation, Homologous
1
2004
415
0.050
Why?
Ovary
1
2005
235
0.050
Why?
Peroneal Nerve
2
2001
18
0.050
Why?
Educational Measurement
1
2006
329
0.050
Why?
Infusions, Intravenous
2
2016
429
0.050
Why?
Myocardial Ischemia
2
2001
286
0.050
Why?
Cimetidine
1
2002
12
0.050
Why?
Ambulatory Care
2
2000
627
0.050
Why?
Paget Disease, Extramammary
1
2002
4
0.050
Why?
Health Status
1
2008
822
0.050
Why?
Decision Making
2
2019
987
0.050
Why?
Facial Neoplasms
1
2002
19
0.040
Why?
Histamine H2 Antagonists
1
2002
22
0.040
Why?
Recurrence
3
2001
1125
0.040
Why?
Interviews as Topic
1
2006
926
0.040
Why?
Vitamin B 12 Deficiency
1
2002
81
0.040
Why?
HIV Infections
1
2017
3210
0.040
Why?
Parkinson Disease
1
2008
614
0.040
Why?
Evidence-Based Medicine
2
2016
727
0.040
Why?
Colorimetry
1
2021
12
0.040
Why?
Patient Selection
1
2006
720
0.040
Why?
Mass Screening
1
2010
1300
0.040
Why?
Reagent Kits, Diagnostic
1
2021
33
0.040
Why?
Drug Therapy
1
2002
85
0.040
Why?
Coronary Artery Disease
1
2008
751
0.040
Why?
Indicators and Reagents
1
2021
105
0.040
Why?
Nasopharynx
1
2021
72
0.040
Why?
Electrophysiology
3
2000
219
0.040
Why?
Valsalva Maneuver
1
2021
8
0.040
Why?
Morbidity
1
2022
317
0.040
Why?
Axilla
1
2001
51
0.040
Why?
Fatal Outcome
2
2000
302
0.040
Why?
Sodium Channel Blockers
1
2001
23
0.040
Why?
Survival Analysis
2
2001
1372
0.040
Why?
Fibrosarcoma
1
2000
22
0.040
Why?
Potassium Channel Blockers
1
2001
47
0.040
Why?
NG-Nitroarginine Methyl Ester
1
2000
48
0.040
Why?
Action Potentials
3
2000
498
0.040
Why?
Orbital Neoplasms
1
2000
28
0.040
Why?
Depression
2
2008
1566
0.040
Why?
Animals
13
2021
38030
0.040
Why?
Volunteers
1
2000
39
0.040
Why?
Retreatment
1
2000
79
0.040
Why?
Bundle of His
1
2000
19
0.040
Why?
Parasympathectomy
1
2000
1
0.040
Why?
Shoulder
1
2001
105
0.040
Why?
Bundle-Branch Block
1
2000
37
0.040
Why?
United States Food and Drug Administration
2
2001
207
0.040
Why?
Epidemics
1
2021
97
0.040
Why?
Sarcoma, Experimental
1
2000
6
0.040
Why?
Infant, Newborn
1
2012
6449
0.040
Why?
Tumor Necrosis Factor-alpha
1
2005
1223
0.040
Why?
Workflow
1
2021
181
0.040
Why?
Nitric Oxide Synthase
1
2000
233
0.040
Why?
Specimen Handling
1
2021
178
0.040
Why?
Survival Rate
2
2004
2078
0.040
Why?
Tilt-Table Test
1
1999
5
0.040
Why?
Maximum Allowable Concentration
1
1999
15
0.040
Why?
Thromboembolism
1
2021
129
0.040
Why?
Angelica sinensis
1
1999
2
0.040
Why?
Prothrombin Time
1
1999
32
0.040
Why?
Thoracotomy
2
1997
87
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2021
973
0.040
Why?
International Normalized Ratio
1
1999
55
0.040
Why?
Transitional Care
1
2019
46
0.040
Why?
Self Report
1
2024
869
0.040
Why?
Referral and Consultation
1
2006
878
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2005
1429
0.040
Why?
Data Display
1
1999
20
0.040
Why?
Emergency Service, Hospital
2
2026
2357
0.040
Why?
Multimorbidity
1
2019
65
0.040
Why?
Electromagnetic Fields
1
1999
37
0.040
Why?
Telephone
3
1995
175
0.040
Why?
Weight Loss
1
2005
857
0.040
Why?
Intraoperative Period
1
1999
68
0.040
Why?
Rhabdomyolysis
1
2019
24
0.040
Why?
Cisplatin
2
1993
346
0.040
Why?
Abnormalities, Drug-Induced
1
1999
38
0.040
Why?
Secondary Prevention
1
2000
247
0.040
Why?
Diagnosis, Differential
2
2000
1500
0.030
Why?
Heart Diseases
2
2005
341
0.030
Why?
Kidney Transplantation
1
2005
702
0.030
Why?
Drug Synergism
1
1999
353
0.030
Why?
Delirium
1
2019
106
0.030
Why?
Heart Failure, Systolic
1
2018
26
0.030
Why?
Heart Ventricles
2
2000
762
0.030
Why?
Hydrogen
1
1998
73
0.030
Why?
Echocardiography
2
1998
645
0.030
Why?
Cerebral Hemorrhage
1
2019
125
0.030
Why?
Qualitative Research
1
2006
1720
0.030
Why?
Maternal-Fetal Exchange
1
1999
171
0.030
Why?
Heart Block
1
1997
41
0.030
Why?
Child
3
2015
22638
0.030
Why?
Resuscitation
1
2000
314
0.030
Why?
Ventricular Dysfunction, Right
1
2000
248
0.030
Why?
Cannabis
1
2024
519
0.030
Why?
Digoxin
1
1997
27
0.030
Why?
Bread
1
1997
2
0.030
Why?
Evaluation Studies as Topic
2
1994
160
0.030
Why?
Body Surface Area
1
1997
33
0.030
Why?
Edible Grain
1
1997
45
0.030
Why?
Signal Transduction
1
2010
5234
0.030
Why?
Administration, Inhalation
1
1998
567
0.030
Why?
Magnetic Resonance Spectroscopy
3
1994
627
0.030
Why?
Energy Intake
1
2019
506
0.030
Why?
Nutritional Requirements
1
1997
78
0.030
Why?
Sensitivity and Specificity
1
2021
1992
0.030
Why?
Voltage-Gated Sodium Channel Blockers
1
2016
7
0.030
Why?
Chromatography, Gas
1
2016
30
0.030
Why?
Blood Cell Count
1
1996
56
0.030
Why?
Frailty
1
2019
206
0.030
Why?
Electric Conductivity
1
1996
85
0.030
Why?
Anesthetics
1
2017
100
0.030
Why?
Propensity Score
1
2018
370
0.030
Why?
Electric Stimulation
1
1997
271
0.030
Why?
Surface Properties
1
1997
383
0.030
Why?
Adrenergic beta-Agonists
1
1996
91
0.030
Why?
Statistics, Nonparametric
1
2016
423
0.030
Why?
Physician-Patient Relations
1
2020
595
0.030
Why?
Neutropenia
1
1996
153
0.030
Why?
Forecasting
1
1997
386
0.030
Why?
Factor X
1
2014
26
0.030
Why?
Diabetes Mellitus
2
2019
1101
0.030
Why?
Perioperative Care
1
2017
229
0.030
Why?
Preoperative Care
1
2017
375
0.030
Why?
Precision Medicine
1
2018
462
0.030
Why?
Central Nervous System Stimulants
1
2016
183
0.030
Why?
Thrombocytopenia
1
1996
205
0.030
Why?
Stochastic Processes
1
1994
64
0.020
Why?
Psychiatric Status Rating Scales
1
2016
512
0.020
Why?
PubMed
1
2013
15
0.020
Why?
Medical Assistance
1
2013
13
0.020
Why?
Education, Pharmacy, Graduate
1
2013
13
0.020
Why?
Acecainide
1
1993
2
0.020
Why?
Reoperation
1
2016
633
0.020
Why?
Confidence Intervals
1
1994
328
0.020
Why?
Heparin
1
2014
246
0.020
Why?
Disaster Planning
1
2014
109
0.020
Why?
Outpatient Clinics, Hospital
1
2013
80
0.020
Why?
Pregnancy Trimester, Third
1
1993
116
0.020
Why?
Medication Therapy Management
1
2013
73
0.020
Why?
Program Development
1
2014
365
0.020
Why?
Antibodies
1
2014
395
0.020
Why?
Imaging, Three-Dimensional
1
2016
578
0.020
Why?
Education
1
2012
102
0.020
Why?
Surgical Wound Infection
1
1995
331
0.020
Why?
Program Evaluation
1
2016
945
0.020
Why?
Biological Availability
1
1992
146
0.020
Why?
Therapeutic Equivalency
1
2011
31
0.020
Why?
Internationality
1
2012
156
0.020
Why?
Stroke
1
2021
1283
0.020
Why?
History, 21st Century
1
2012
224
0.020
Why?
Urinary Retention
1
2011
23
0.020
Why?
Random Allocation
1
1992
365
0.020
Why?
Genotype
1
2016
1866
0.020
Why?
Self Care
1
2014
396
0.020
Why?
History, 20th Century
1
2012
330
0.020
Why?
Neoplasms, Experimental
1
1992
163
0.020
Why?
Staphylococcal Infections
1
1995
396
0.020
Why?
Kidney
1
2019
1491
0.020
Why?
Neuropsychological Tests
1
2016
1136
0.020
Why?
Body Temperature
1
1992
227
0.020
Why?
Neutrophils
1
1996
1132
0.020
Why?
Liver
1
2019
1859
0.020
Why?
Chemoprevention
1
2010
91
0.020
Why?
Brain Neoplasms
1
1999
1324
0.020
Why?
Guideline Adherence
1
2014
585
0.020
Why?
Reference Values
1
1991
787
0.020
Why?
Micronutrients
1
2010
102
0.020
Why?
Heart
2
1995
624
0.020
Why?
Journal Impact Factor
1
2009
29
0.020
Why?
Biomarkers
2
2016
4329
0.020
Why?
Food
1
2010
149
0.020
Why?
Patient Satisfaction
1
2013
698
0.020
Why?
Longitudinal Studies
1
2016
3005
0.020
Why?
Up-Regulation
1
2010
840
0.020
Why?
Tricuspid Valve
1
1987
42
0.020
Why?
Quality of Health Care
1
2012
692
0.020
Why?
Internship, Nonmedical
1
2006
10
0.020
Why?
Cross Reactions
1
2006
129
0.020
Why?
Specialty Boards
1
2006
41
0.010
Why?
Schools, Pharmacy
1
2006
48
0.010
Why?
Probability
1
2006
308
0.010
Why?
WW Domain-Containing Oxidoreductase
1
2005
3
0.010
Why?
Caregivers
1
2015
1079
0.010
Why?
Tomography, X-Ray Computed
1
2016
2766
0.010
Why?
Hydrogen-Ion Concentration
2
2000
533
0.010
Why?
Temperature
3
1999
633
0.010
Why?
Faculty
1
2006
151
0.010
Why?
Furosemide
1
2005
37
0.010
Why?
Molecular Structure
1
2006
483
0.010
Why?
Loss of Heterozygosity
1
2005
51
0.010
Why?
Genes, Tumor Suppressor
1
2005
84
0.010
Why?
Antimetabolites
1
2004
21
0.010
Why?
Growth Inhibitors
1
2004
39
0.010
Why?
Homozygote
1
2005
196
0.010
Why?
Immunoblotting
1
2005
294
0.010
Why?
Azathioprine
1
2004
43
0.010
Why?
Antineoplastic Agents
1
1996
2218
0.010
Why?
Gout
1
2005
34
0.010
Why?
Diphosphonates
1
2005
67
0.010
Why?
Everolimus
1
2004
112
0.010
Why?
Magnetic Resonance Imaging
2
1994
3917
0.010
Why?
Hypolipidemic Agents
1
2005
89
0.010
Why?
Mycophenolic Acid
1
2004
117
0.010
Why?
Hyperlipidemias
1
2005
120
0.010
Why?
Gene Deletion
1
2005
384
0.010
Why?
Receptors, Progesterone
1
2005
241
0.010
Why?
Mice
1
2021
18266
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2005
751
0.010
Why?
Myocardial Contraction
2
1999
292
0.010
Why?
Infection Control
1
2005
174
0.010
Why?
Sirolimus
1
2004
282
0.010
Why?
Blood Glucose
1
1993
2357
0.010
Why?
Tumor Suppressor Proteins
1
2005
314
0.010
Why?
Protein Kinases
1
2004
311
0.010
Why?
Blotting, Western
1
2005
1176
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2005
845
0.010
Why?
Algorithms
1
2010
1843
0.010
Why?
Ambulatory Care Facilities
1
2005
267
0.010
Why?
Cheek
1
2002
14
0.010
Why?
Nutritional Status
1
2005
344
0.010
Why?
Methylmalonic Acid
1
2002
66
0.010
Why?
Mohs Surgery
1
2002
30
0.010
Why?
Legislation, Medical
1
2001
11
0.010
Why?
Device Approval
1
2001
19
0.010
Why?
Osteoporosis
1
2005
239
0.010
Why?
Homocysteine
1
2002
152
0.010
Why?
Adrenal Cortex Hormones
1
2004
483
0.010
Why?
TOR Serine-Threonine Kinases
1
2004
454
0.010
Why?
Immunohistochemistry
1
2005
1709
0.010
Why?
Partial Pressure
1
2000
30
0.010
Why?
Parasympathetic Nervous System
1
2000
26
0.010
Why?
Gastroesophageal Reflux
1
2002
232
0.010
Why?
Echocardiography, Doppler, Pulsed
1
1999
13
0.010
Why?
Central Venous Pressure
1
1999
17
0.010
Why?
Epinephrine
1
2000
160
0.010
Why?
Postoperative Period
1
2000
344
0.010
Why?
Radiotherapy Dosage
1
1999
289
0.010
Why?
Neovascularization, Pathologic
1
2000
285
0.010
Why?
Biopsy
1
2002
1073
0.010
Why?
Echocardiography, Transesophageal
1
1999
132
0.010
Why?
Protein Kinase Inhibitors
1
2004
982
0.010
Why?
Bone Neoplasms
1
2000
271
0.010
Why?
Blood Flow Velocity
1
1999
419
0.010
Why?
Cutaneous Fistula
1
1995
17
0.010
Why?
Oxygen
1
2000
996
0.010
Why?
Foreign Bodies
1
1995
109
0.010
Why?
Antigens, Tumor-Associated, Carbohydrate
1
1993
8
0.010
Why?
Peritoneal Cavity
1
1993
30
0.010
Why?
Infusions, Parenteral
1
1993
47
0.010
Why?
Intracellular Fluid
1
1993
25
0.010
Why?
Half-Life
1
1993
157
0.010
Why?
Microelectrodes
1
1993
49
0.010
Why?
Wolff-Parkinson-White Syndrome
1
1993
19
0.010
Why?
Monitoring, Physiologic
1
1995
278
0.010
Why?
Extracellular Space
1
1993
118
0.010
Why?
Phosphates
1
1994
175
0.010
Why?
Survivors
1
1996
521
0.010
Why?
Stimulation, Chemical
1
1992
52
0.010
Why?
Proportional Hazards Models
1
1995
1318
0.010
Why?
Regional Blood Flow
1
1993
507
0.010
Why?
Adenosine Triphosphate
1
1994
494
0.010
Why?
Hepatitis, Animal
1
1987
2
0.000
Why?
Endocardium
1
1987
31
0.000
Why?
Injections, Intraperitoneal
1
1987
115
0.000
Why?
Tachycardia
1
1987
58
0.000
Why?
Peritonitis
1
1987
82
0.000
Why?
Tissue Distribution
1
1987
334
0.000
Why?
Drug Evaluation, Preclinical
1
1987
195
0.000
Why?
In Vitro Techniques
1
1987
1041
0.000
Why?
Lymph Nodes
1
1987
511
0.000
Why?
Pulmonary Fibrosis
1
1987
395
0.000
Why?
Child, Preschool
1
1994
11888
0.000
Why?
Disease Models, Animal
1
1987
4565
0.000
Why?
Page's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)